Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Healthcare industry welcomes decision to yank ACA replacement bill

Groups representing physicians, family medicine and hospitals were pleased to see the American Health Care Act (AHCA), the Republican-sponsored replacement to the Affordable Care Act (ACA), tabled before a scheduled House vote on March 24—even though it left plenty of uncertainty for insurance markets.

Thumbnail

Q&A: Wireless patient monitoring has mothers dancing for joy

Patient monitoring is starting even before the patient arrives, with Novii, mothers can sit, walk and even dance their way through labor while fetal heart rate is monitored wirelessly.

Thumbnail

ACA replacement bill pulled before House vote

In a victory for the major medical organizations opposed to it, a scheduled vote in the House on the American Health Care Act (AHCA) was called off as Republican leaders failed to convince enough of their own members to support the plan to replace the Affordable Care Act (ACA).

Thumbnail

ACHE 2017: Inclusive culture in healthcare is more than 'checking boxes' on diversity

Most healthcare conferences these days seem to include sessions on promoting diversity in organizations and among leadership. Two Monday sessions at the American College of Healthcare Executives’ (ACHE) 2017 Congress in Chicago are taking a different aim to change how leaders think about diversity and focus on creating a “culture of inclusion.”

Improved pathogen detection with lab-on-a-chip

Lab-on-a-chip technology is advancing pathogen detection in individual samples, without the need for complex bulky equipment. Developed by Natalia Sandetskaya and colleagues at the Fraunhofer Institute for Cell Therapy & Immunology in Leipzig, Germany, the prototype lab-on-a-chip automates the detection process within a single device. 

Thumbnail

D.C. hospital first to receive Joint Commission/AABB blood transfusion certification

The Joint Commission and the AABB (formerly the American Association of Blood Banks) has awarded its first Patient Blood Management Certification to MedStar-Georgetown University Hospital in Washington, D.C.

Hospitals holding off on expansion projects because of ACA uncertainty

With the ultimate fate of the Affordable Care Act (ACA) and healthcare policy remaining a mystery under a Republican-controlled Congress and President Donald Trump, some U.S. hospitals have decided this isn’t the right time to take on big projects.

CBO: ACA replacement changes save less money, don’t improve coverage

An updated assessment on the American Health Care Act (AHCA) from the Congressional Budget Office (CBO) said amendments to the Republican-sponsored Affordable Care Act replacement plan wouldn’t improve its losses in insurance coverage and would decrease the amount of savings to the federal budget. 

Displaying 4825 - 4832 of 6646

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup